The association of 6-minute walk performance and outcomes in stable outpatients with heart failure

Journal of Cardiac Failure

Volumn 10, Issue 1, 2004, Pages 9-14

  Curtis, Jeptha P ^a   Rathore, Saif S ^a   Wang, Yongfei ^a   Krumholz, Harlan M ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

6 minute walk test; heart failure; prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD; HEART DEATH; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MORTALITY; MULTIVARIATE ANALYSIS; OUTPATIENT; PRIORITY JOURNAL;

AGED; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; WALKING;

EID: 3042858193     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2003.08.010     Document Type: Article

References (23)

1. Bittner V., Weiner D.H., Yusuf S., Rogers W.J., McIntyre K.M., Bangdiwala S.I., et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA. 270:1993;1702-1707
2. Demers C., McKelvie R.S., Negassa A., Yusuf S. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. Am Heart J. 142:2001;698-703
3. O'Keeffe S.T., Lye M., Donnellan C., Carmichael D.N. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart. 80:1998;377-382
4. Shah M.R., Hasselblad V., Gheorghiade M., Adams K.F. Jr., Swedberg K., Califf R.M., et al. Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol. 88:2001;987-993
5. Bettencourt P., Ferreira A., Dias P., Pimenta J., Frioes F., Martins L., et al. Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail. 6:2000;306-313
6. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 38:2001;2101-2113
7. Lucas C., Stevenson L.W., Johnson W., et al. The 6-minute walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. Am Heart J. 138:1999;618-624
8. Roul G., Germain P., Bareiss P. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J. 136:1998;449-457
9. Cahalin L.P., Mathier M.A., Semigran M.J., et al. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest. 110:1996;325-332
10. Opasich C., Pinna G.D., Mazza A., et al. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Eur Heart J. 22:2001;488-496
11. The Digitalis Investigation Group. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. Controlled Clin Trials. 17:1996;77-97
12. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 336:1997;525-533
13. Guyatt G.H., Sullivan M.J., Thompson P.J., et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. CMAJ. 132:1985;919-923
14. Bourassa M.G., Gurne O., Bangdiwala S.I., et al. Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol. 22:1993;14A-19A
15. Bart B.A., Shaw L.K., McCants C.B. Jr., et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol. 30:1997;1002-1008
16. Adams K.F. Jr., Dunlap S.H., Sueta C.A., et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol. 28:1996;1781-1788
17. Drazner M.H., Rame J.E., Stevenson L.W., et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 345:2001;574-581
18. Sprent P. Applied nonparametric statistical methods. 2nd ed. 1993;Chapman and Hall, London
19. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41
20. Royston P., Ambler G., Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 28:1999;964-974
21. Rathore S.S., Wang Y., Krumholz H.M. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med. 347:2002;1403-1411
22. Rostagno C., Galanti G., Romano M., et al. Prognostic value of 6-minute walk corridor testing in women with mild to moderate heart failure. Ital Heart J. 3:2002;109-113
23. Bittner V. Determining prognosis in congestive heart failure: role of the 6-minute walk test. Am Heart J. 139:1999;593-596